Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating endothelial cells as potential diagnostic biomarkers in primary central nervous system vasculitis.
Deb-Chatterji M, Gerdes S, Heeren M, Lambrecht J, Worthmann H, Goldbecker A, Tryc AB, Lovric S, Schulz-Schaeffer W, Brandis A, Dengler R, Weissenborn K, Haubitz M. Deb-Chatterji M, et al. Among authors: gerdes s. J Neurol Neurosurg Psychiatry. 2013 Jul;84(7):732-4. doi: 10.1136/jnnp-2012-303335. Epub 2012 Dec 15. J Neurol Neurosurg Psychiatry. 2013. PMID: 23243263
Efficacy and safety of guselkumab in European patients with palmoplantar pustulosis: A multi-center, single-arm clinical trial (GAP study).
Wilsmann-Theis D, Patt S, Pinter A, Gerdes S, Magnolo N, Németh R, Schmitz J, Paul C, Augustin M, Staubach P, Weyergraf A, Hüffmeier U, Wolk K, Sabat R, Mößner R. Wilsmann-Theis D, et al. Among authors: gerdes s. JAAD Int. 2024 Oct 2;18:69-78. doi: 10.1016/j.jdin.2024.09.001. eCollection 2025 Feb. JAAD Int. 2024. PMID: 39618912 Free PMC article.
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.
Ständer S, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Metz M, Tsianakas A, Pink A, Fage S, Micali G, Weisshaar E, Sundaram H, Metelitsa A, Augustin M, Wollenberg A, Homey B, Fargnoli MC, Sofen H, Korman NJ, Skov L, Chen X, Jabbar-Lopez ZK, Piketty C, Kwatra SG; OLYMPIA 1 Investigators. Ständer S, et al. JAMA Dermatol. 2024 Nov 27. doi: 10.1001/jamadermatol.2024.4796. Online ahead of print. JAMA Dermatol. 2024. PMID: 39602139
Anti-TNF therapy impairs both short- and long-term IgG responses after repeated vaccination.
Buhre JS, Pongracz T, Geisen UM, Schubert M, Wang W, Nouta J, Obara M, Lehrian S, Rahmöller J, Petry J, Tran F, Schreiber S, Sümbül M, Berner D, Gerdes S, Schirmer J, Longardt AC, Hoff P, Kalinke U, Ludwig RJ, Bartsch YC, Hoyer BF, Wuhrer M, Ehlers M. Buhre JS, et al. Among authors: gerdes s. Allergy. 2024 Jul 25. doi: 10.1111/all.16241. Online ahead of print. Allergy. 2024. PMID: 39049686
231 results